Profile image
Story Views

Last Hour:
Last 24 Hours:

What Recent Developments Could Drive in Preimplantation genetic diagnosis (PGD) Market

Thursday, February 23, 2017 23:02
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Preimplantation genetic diagnosis (PGD) also referred as embryo screening, is a branch of genetics involves in genetic testing of embryo through in-vitro fertilization (IVF). PGD eliminates risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal, or hereditary disorders such as spinal muscular atrophy and cystic fibrosis.

Enquire about the Complete Report here:

The global PGD market size is estimated to be $79.5 million in 2015 and expected to reach $121.5 million registering a CAGR of 6.14% from 2016 to 2022. The global PGD market is expected to witness notable growth in the near future owing to the rise in prevalence of genetic, hereditary, and chromosomal diseases. Moreover, PGD have high chances of conceiving healthy embryos. However, the high costs incurred in the PGD technologies hamper the market growth. Moreover, stringent government regulations and ethical concerns also obstruct the market growth. In the near future, increase is expected in adoption of PGD worldwide owing to its various applications for development of healthy embryo.

To Order For a Sample Report Copy, Please Visit:

The global PGD market is segmented based on the test type and geography. Based on type, the market can be segmented into aneuploidy, chromosomal abnormalities, gender selection, HLA typing, single gene disorder, X-linked diseases, and others (disability, and adult onset disease). Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA.

The key market players are Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., and Reproductive Genetics Innovations LLC.

Browse Complete report @


  • In-depth study of the global preimplantation genetic diagnostic market was conducted based on current testing trends of genetic test and based on the preferences for designer babies
  • Potential analysis of opportunities was evaluated for understanding different aspects of preimplantation genetic test that are currently under various phases of clinical trials along with the variants that would gain prominence in the future
  • A deep analysis of key market dynamics that influence the adoption of PGD tests in the forecast period
  • Analysis of volume and vale share analysis of PGD testing at a global and regional level
  • Key market players are profiled and their strategies are analyzed thoroughly for understanding the various technologies adopted by them for development and production of diagnostic tests for PGD testing

About Us:

Our strength is in our research analysts who with their proactive approach are able to source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.

Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.

Contact Big Market Research:

Direct Contact: + 1-503-894-6022
Toll Free: + 1-800-910-6452

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.